These results demonstrate that RANK expression in breast cancer MDA-231 cells, independently of increased bone turnover, is required for their migratory response toward RANKL-expressing bone cells in vivo in response to sympathetic activation. The gene discussed is TNFRSF11A; the disease is breast cancer.